Heald Adrian H, Gimeno Lucia Albeda, Gilingham Erin, Hudson Lynne, Price Lisa, Saboo Anuj, Beresford Laura, Seviour Sally, White Alison, Roberts Sarah, Abraham Jonathan
Department of Diabetes and Endocrinology, Salford Royal Hospital, Salford.
The School of Medicine and Manchester Academic Health Sciences Centre, University of Manchester, Manchester.
Cardiovasc Endocrinol Metab. 2022 Jul 19;11(3):e0268. doi: 10.1097/XCE.0000000000000268. eCollection 2022 Sep.
The use of personalised care planning has been effective at improving health outcomes for people with long-term health conditions.
We analysed data in relation to changes in BMI/HbA1c. The sample was made up of ( = 36) participants randomised to either the active intervention group (App+usual care) or the control group (usual care).
The average HbA1c percentage change for the treatment group was 9.5%, but just -2% for the control (usual care) group ( = 0.015 for the difference). The average percentage change in BMI for the treatment group was -0.4%, but 0.1% for the control group ( = 0.03 for the difference).
These preliminary findings point to how the provision of personalised plans of care, support and education linked to a mobile app, can result in HbA1c and BMI reduction over a 6-month period. While the results are preliminary, they portend the potential for digital plans of care to enhance T2DM management.
使用个性化护理计划已有效改善了患有长期健康问题的人群的健康状况。
我们分析了与体重指数（BMI）/糖化血红蛋白（HbA1c）变化相关的数据。样本由36名参与者组成，他们被随机分配到积极干预组（应用程序+常规护理）或对照组（常规护理）。
治疗组的糖化血红蛋白平均百分比变化为9.5%，而对照组（常规护理）仅为-2%（差异P值=0.015）。治疗组体重指数的平均百分比变化为-0.4%，而对照组为0.1%（差异P值=0.03）。
这些初步研究结果表明，提供与移动应用程序相关的个性化护理、支持和教育计划，可在6个月内降低糖化血红蛋白和体重指数。虽然结果是初步的，但它们预示着数字护理计划在改善2型糖尿病管理方面的潜力。
